1-Hydroxybenzotriazole → 2,2,3,3-Tetramethylcyclopropanecarboxylic acid (4-methyl-5-morpholin-4-yl-thiazol-2-yl)-amide

HRID 78417

反応式

[CH3:1][C:2]1[N:3]=[C:4]([NH2:13])[S:5][C:6]=1[N:7]1[CH2:12][CH2:11][O:10][CH2:9][CH2:8]1.CCN=C=NCCCN(C)C.Cl.ON1C2C=CC=CC=2N=N1.[CH3:36][C:37]1([CH3:45])[C:39]([CH3:41])([CH3:40])[CH:38]1[C:42](O)=[O:43]>C(N(CC)CC)C>[CH3:1][C:2]1[N:3]=[C:4]([NH:13][C:42]([CH:38]2[C:39]([CH3:41])([CH3:40])[C:37]2([CH3:45])[CH3:36])=[O:43])[S:5][C:6]=1[N:7]1[CH2:8][CH2:9][O:10][CH2:11][CH2:12]1

参加物

実験手順

A mixture of 4-methyl-5-morpholin-4-yl-thiazol-2-ylamine (prepared using the method described in Christopher et al., Bioorganic and Medicinal Chemistry Letters 2004, 14(22), 5521-5525), N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride, 1-hydroxybenzotriazole, triethylamine, and 2,2,3,3-tetramethylcyclopropanecarboxylic acid were processed using the method described in Example 58 to afford the title compound. MS (ESI) m/z 324 (M+H)+.

後処理

customprepared

出典と根拠

ORDレコード: ord-36a87c5f875f426fa49b4967c0c7dab9
出典データセット: uspto-grants-2014_09
DOI: 10.6084/m9.figshare.5104873.v1
特許番号: US08841334B2

反応式

参加物

反応物 4

生成物 1

試薬・触媒・溶媒 1

実験手順

後処理

出典と根拠

関連ノート